F. Schindel

1.7k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

F. Schindel is a scholar working on Molecular Biology, Epidemiology and Hematology. According to data from OpenAlex, F. Schindel has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in F. Schindel's work include Sepsis Diagnosis and Treatment (3 papers), Statistical Methods in Clinical Trials (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). F. Schindel is often cited by papers focused on Sepsis Diagnosis and Treatment (3 papers), Statistical Methods in Clinical Trials (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). F. Schindel collaborates with scholars based in Germany, United States and Sweden. F. Schindel's co-authors include H. Heinrichs, Sigurd Knaub, István Pénzes, S. Pillay, A Kübler, Pavel Chalupa, Heinz-Otto Keinecke, Peder Carl, for the Mexican Nephrology Collaborative Study Group and Alain Eid and has published in prestigious journals such as JAMA, European Heart Journal and Statistics in Medicine.

In The Last Decade

F. Schindel

11 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Dose Antithrombin III in Severe Sepsis

2001 937 citations Brian Warren, Alain Eid et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Schindel Germany	10	717	379	293	207	171	13	1.2k
István Pénzes Hungary	8	710 1.0×	331 0.9×	286 1.0×	192 0.9×	161 0.9×	22	1.2k
Pierre Singer Israel	5	693 1.0×	315 0.8×	276 0.9×	189 0.9×	187 1.1×	16	1.0k
Franklin A. Bontempo United States	25	418 0.6×	493 1.3×	457 1.6×	203 1.0×	778 4.5×	51	2.1k
Burkhard Vangerow United States	9	626 0.9×	136 0.4×	263 0.9×	61 0.3×	246 1.4×	14	1.1k
Aldo Salvi Italy	17	285 0.4×	342 0.9×	144 0.5×	412 2.0×	116 0.7×	49	1.4k
Anthony Dal Nogare United States	7	609 0.8×	121 0.3×	282 1.0×	73 0.4×	202 1.2×	7	1.4k
Anne Riddell United Kingdom	26	261 0.4×	871 2.3×	262 0.9×	189 0.9×	342 2.0×	68	1.7k
Robert J. Porte Netherlands	22	487 0.7×	402 1.1×	309 1.1×	81 0.4×	952 5.6×	50	1.8k
Martina Brückmann Germany	4	438 0.6×	93 0.2×	153 0.5×	49 0.2×	106 0.6×	5	641
Simon Davidson United Kingdom	23	353 0.5×	312 0.8×	232 0.8×	198 1.0×	362 2.1×	53	1.3k

Countries citing papers authored by F. Schindel

Since Specialization

Citations

This map shows the geographic impact of F. Schindel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Schindel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Schindel more than expected).

Fields of papers citing papers by F. Schindel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Schindel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Schindel. The network helps show where F. Schindel may publish in the future.

Co-authorship network of co-authors of F. Schindel

This figure shows the co-authorship network connecting the top 25 collaborators of F. Schindel. A scholar is included among the top collaborators of F. Schindel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Schindel. F. Schindel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Bernstein, Jonathan A., Bruce Ritchie, Robyn J. Levy, et al.. (2010). Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 105(2). 149–154. 24 indexed citations

2.

Praus, Michaela, et al.. (2004). Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin. The Journal of Clinical Pharmacology. 45(1). 57–67. 48 indexed citations

3.

Hoots, W. Keith, Cindy Leissinger, Bruce A. Schwartz, et al.. (2003). Continuous intravenous infusion of a plasma‐derived factor IX concentrate (Mononine^®) in haemophilia B. Haemophilia. 9(2). 164–172. 25 indexed citations

4.

Eid, Alain, Peter P. Singer, S. Pillay, et al.. (2001). High-dose a randomized antithrombin III in severe sepsis - A randomized controlled trial.. JAMA. 286(15). 2 indexed citations

5.

Warren, Brian, Alain Eid, Pierre Singer, et al.. (2001). High-Dose Antithrombin III in Severe Sepsis. JAMA. 286(15). 1869–1869. 937 indexed citations breakdown →

6.

Ilias, W., Johan Decruyenaere, Sigurd Knaub, et al.. (2000). Antithrombin III in patients with severe sepsis: a pharmacokinetic study. Intensive Care Medicine. 26(6). 704–715. 46 indexed citations

7.

Schindel, F.. (2000). Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study. European Journal of Clinical Pharmacology. 56(9-10). 685–688. 12 indexed citations

8.

Häfner, G., H.-J. Rupprecht, Wolfram Terres, et al.. (1996). Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris. European Heart Journal. 17(8). 1207–1215. 17 indexed citations

9.

Ohlman, S., et al.. (1994). Pharmacokinetics of 15-deoxyspergualin studied in renal transplant patients receiving the drug during graft rejection. Transplant International. 7(1). 5–10. 14 indexed citations

10.

Ohlman, S., et al.. (1994). Pharmacokinetics of 15-deoxyspergualin studied in renal transplant patients receiving the drug during graft rejection. Transplant International. 7(1). 5–10. 15 indexed citations

11.

Praus, Michaela, et al.. (1993). Alert systems for post‐marketing surveillance of adverse drug reactions. Statistics in Medicine. 12(24). 2383–2393. 29 indexed citations

12.

Schindel, F., et al.. (1991). Stratified or Multicentre Analysis with Extended Mantel–Haenszel Statistics. Biometrical Journal. 33(6). 755–762.

13.

Oster, Wolfgang, F. Schindel, & H. Heinrichs. (1991). Clinical evaluation of erythropoietin (EPO) in oncology.. PubMed. 62–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact